ID
45967
Descrição
Principal Investigator: Jennifer R. Brown, Dana-Farber Cancer Institute, Broad Institute, Boston, MA, USA MeSH: Leukemia, Lymphocytic, Chronic, B-Cell https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000879 Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by accumulation of CD5+CD19+ B cells in peripheral lymphoid organs, bone marrow and blood. In this study we analyze matched whole genome sequencing and RNA-seq data from CLL patients to characterize the mutational processes operative throughout tumor evolution. Source of tumor and normal DNA used is patient PBMC or B cells and saliva respectively.
Link
Palavras-chave
Versões (1)
- 26/03/2024 26/03/2024 - Madita Rudolph
Titular dos direitos
Jennifer R. Brown, Dana-Farber Cancer Institute, Broad Institute, Boston, MA, USA
Transferido a
26 de março de 2024
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs000879 DFCI Brown Lab CLL Sequencing Study
Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- StudyEvent: SEV1
- Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
Similar models
Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- StudyEvent: SEV1
- Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
C1299222 (UMLS CUI [1,2])